How Cosmetic Formulation Turns a Beauty Idea Into a Manufacturable Product

01

What cosmetic formulation really involves

A formula is a connected product system

Cosmetic formulation is more than combining attractive ingredients. A formulator balances the product format, intended use, sensory profile, ingredient compatibility, preservation approach, processing method, packaging and the evidence needed for the target market. A serum that feels elegant in a sample vial may behave differently in a dropper, while a rich cream designed for a jar creates different use and contamination considerations from an airless format.

Translate brand language into observable criteria

The work begins by translating commercial language into technical choices. “Lightweight” might mean rapid spread, low residue and a particular viscosity range. “Premium” might refer to slip, absorption, fragrance restraint and the way the formula leaves the skin, not to one expensive ingredient. A useful brief defines these experiences in observable terms so the development team can build and compare prototypes.

Plan evidence around the actual product

The U.S. Food and Drug Administration explains that there is no universal list of tests required for every cosmetic, but the business marketing the product remains responsible for safety and may need scientifically sound testing to fill evidence gaps. That FDA product-testing guidance is a useful reminder that formulation, safety evidence and testing decisions have to be product-specific.

• Product purpose, target user and expected use frequency.
• Format, texture, finish, fragrance and appearance direction.
• Ingredient preferences, exclusions and market restrictions.
• Primary packaging, fill size and dispensing expectations.
• Target markets, claims territory and launch timing.

02

Build the product brief before choosing ingredients

Define the customer decision first

A strong product brief starts with the decision the customer is making. Is the product intended to be a daily hydration step, a cleansing format, a body-care treatment or the anchor of a short routine? Who buys it, where will it be sold and what should distinguish it from the rest of the range? These questions give the formulator a clearer design space than a request for a long list of trending actives.

Separate requirements from preferences

Next, separate essentials from preferences. Essentials may include the product format, market, pack type, fragrance position or ingredients that cannot be used. Preferences may include a target colour, a benchmark feel or an aspiration for a certain finish. Recording that hierarchy helps the team preserve the product idea when an ingredient, component or processing constraint requires a change.

Choose the right development route

For a brand beginning with an established private label formula route, the work may focus on selecting and presenting an existing base. A project requiring a defined benchmark or specification may fit OEM skincare development, while a more original concept may need the wider discovery and prototype work described in LUXA’s ODM skincare route. Choosing the route early avoids asking every sample round to solve a different kind of problem.

03

Turn sensory language into a formula direction

Describe the experience in stages

Texture is often the first thing a customer notices and one of the hardest qualities to describe consistently. Words such as silky, cushiony, fresh, rich or fast-absorbing can mean different things to different reviewers. A better approach breaks the experience into stages: pickup from the pack, first spread, playtime, absorption, residue and after-feel.

Use benchmarks as communication tools

Benchmarks can help when they are used precisely. Instead of asking to copy a product, identify what is useful about it: the pump dose, initial slip, low tack, fragrance level or finish after two minutes. Also identify what should be different. This turns a benchmark into a communication tool without making it the complete product brief.

Treat ingredient databases as references, not approvals

Ingredient direction follows the product role. The European Commission’s CosIng database can help teams check common cosmetic ingredient names and regulatory references, but the Commission states clearly that a CosIng entry does not itself mean an ingredient is approved for cosmetic use. Formula suitability still depends on concentration, restrictions, intended use, safety assessment and the destination market.

04

Develop prototypes with controlled feedback

Give every sample round one job

A prototype is a learning tool, not a miniature finished product. Early rounds may test the formula architecture or sensory direction before colour, fragrance and packaging are final. Later rounds should narrow the remaining decisions. If every reviewer comments on every characteristic at every stage, the project can move sideways rather than forward.

Describe observations before proposing fixes

Give each sample an identifiable version and a review purpose. Ask reviewers to use the same amount, application area and observation period where practical. Record what they experienced and the change they want, rather than prescribing a technical fix. “Leaves a noticeable film after five minutes” is clearer feedback than “reduce the emulsifier,” because the formulator can investigate the system.

Keep a versioned decision log

The existing skincare sampling guide provides a route for benchmark, prototype and approval rounds. Use it with a decision log that records who reviewed the sample, what changed, what remained open and which version is approved for the next stage.

05

Keep claims, safety and market context visible

Claims influence the development brief

Formula development cannot be separated from the language used to sell the product. A cosmetic claim about appearance sits in a different regulatory territory from a claim to treat disease or alter the structure or function of the body. The proposed label, website copy and advertising direction should be shared early enough for technical and regulatory reviewers to identify problems before artwork and production are locked.

Organise evidence for qualified review

In the European Union, Regulation (EC) No 1223/2009 requires a safety assessment based on relevant information before a cosmetic is placed on the market. The official EU Cosmetics Regulation also requires the responsible person to keep a Product Information File, including the safety report and manufacturing information. Accurate formula, process and test information must therefore be organised for qualified review.

Do not treat one market file as global approval

For Great Britain, government guidance states that a responsible person must ensure a qualified safety assessment, maintain product information and complete notification before the product is made available. Review the current GB cosmetics requirements for the target market rather than assuming one formula file automatically satisfies every jurisdiction.

06

Evaluate formula and packaging as one product

The pack changes formula performance in use

The primary pack changes how a formula is protected, dispensed and experienced. A low-viscosity serum needs a component that can deliver a controlled dose without leakage. A high-viscosity cream needs an opening, pump or jar geometry that remains usable. A fragrance, solvent or botanical system may also interact with seals, coatings or decoration.

Introduce the intended component early

Bring packaging into the sequence before formula approval becomes absolute. Confirm the material, closure, pump output, fill size, decoration and secondary pack. Then review the selected formula in the intended component under appropriate compatibility, stability, transport and use assessments. Changing the component family late may reopen questions that appeared settled in a laboratory jar.

Record the approved formula-pack combination

LUXA’s custom skincare packaging planning page explains how formula compatibility, component selection, decoration and cartons fit together. Use that workstream to identify which details are design choices and which are technical constraints, then keep the final combination visible in the approval record.

07

Know when a formula is ready to progress

Define readiness with evidence

A formula is ready to progress when the team can identify the approved version, explain the intended use and sensory standard, and list the remaining tests or market reviews without ambiguity. “The founder likes it” is useful but not sufficient. The project also needs a defined component, preliminary specification, processing feasibility and an evidence plan.

Separate sample approval from production release

Do not confuse sample approval with production release. Sample approval closes a defined development decision. Production release should also consider stability and compatibility work, microbiological and safety evidence where relevant, final claims, artwork, component availability, manufacturing instructions and target-market requirements.

Use one final controlled review

A concise release meeting can prevent expensive assumptions. Review the formula code, component code, fill size, artwork version, test status, unresolved deviations and ownership of each next action. If any item still refers to “the latest version” without a number or date, the project is not controlled enough.

• Approved formula version and agreed sensory standard.
• Selected primary packaging and fill configuration.
• Recorded test plan, current results and open follow-up.
• Reviewed claims, label inputs and target-market responsibilities.
• Confirmed quotation assumptions, quantity and production route.

08

Prepare a manufacturer-ready formulation enquiry

Share the decisions that shape feasibility

A useful enquiry does not need to solve the formulation in advance. It should explain the product category, customer, use moment, texture and finish, ingredient direction, packaging preference, target market, expected quantity and launch window. Attach references only when you can explain what should be learned from them.

Make open questions visible

Identify the decisions already made. If the hero product and range role are still open, say so. If a regulatory adviser has defined prohibited claims or ingredient constraints, include them. If the pack is already sourced, provide drawings, material details and samples where available. Clear inputs allow the manufacturer to identify feasibility questions before promising a sample date.

Use the first call to define the next decision

When the brief is ready, share your product direction with LUXA. The first discussion should confirm the development route, required information, sample objective and next decision rather than rush directly to a final formula claim.